(HealthDay)—Withdrawal of antiepileptic drugs (AEDs) in children is tied to higher IQ post-epilepsy surgery, according to a study published online April 21 in the Annals of Neurology.
May 4, 2015
0
8
(HealthDay)—Targeted panel testing has the highest clinical yield for molecular diagnosis of neuromuscular diseases (NMDs), according to a study published in the February issue of the Annals of Neurology.
Feb 13, 2015
0
3
(HealthDay)—For patients with acute coma, reversal and/or limitation of lateral brain displacement is associated with awakening, according to a study published online Jan. 27 in the Annals of Neurology.
Feb 5, 2015
0
5
(HealthDay)—Seasonal relapse onset in multiple sclerosis occurs in both hemispheres and varies with latitude, according to a study published in the December issue of the Annals of Neurology.
Dec 3, 2014
0
0
(HealthDay)—Response to post-stoke restorative therapy is best predicted by a model that includes measures of both neural injury and function, according to research published online Nov. 10 in the Annals of Neurology.
Nov 19, 2014
0
0
New research reveals that bilingualism has a positive effect on cognition later in life. Findings published in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, show that ...
Jun 2, 2014
1
0
A study by Medical Research Council-funded researchers has shown that traumatic brain injuries from explosions can cause hormonal problems. Soldiers who, as a result of their injuries, have problems with their pituitary gland ...
Sep 26, 2013
0
0
Researchers have made an exciting breakthrough – developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians ...
Sep 23, 2013
0
0
Pregnant women who don't make nearly enough thyroid hormone are nearly 4 times likelier to produce autistic children than healthy women, report scientists from the Houston Methodist Neurological Institute and Erasmus Medical ...
Aug 14, 2013
0
1
Results from a clinical trial of eteplirsen, a drug designed to treat Duchenne muscular dystrophy, suggest that the therapy allows participants to walk farther than people treated with placebo and dramatically increases production ...
Aug 8, 2013
0
1
